# Quest Diagnostics (DGX) — Analyst Forecast

DGX · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/dgx/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | Barclays | Maintained | Overweight | $260.00 |
| Sep 21, 2026 | Truist Securities | Maintained | Hold | $260.00 |
| Sep 8, 2026 | UBS | Maintained | Neutral | $245.00 |
| Jul 28, 2026 | JP Morgan | Maintained | Neutral | $250.00 |
| Jul 24, 2026 | Baird | Maintained | Neutral | $255.00 |
| Jul 24, 2026 | Barclays | Maintained | Overweight | $250.00 |
| Jul 24, 2026 | Truist Securities | Maintained | Hold | $250.00 |
| Jul 24, 2026 | Mizuho | Maintained | Outperform | $260.00 |
| Jul 24, 2026 | UBS | Maintained | Neutral | $232.00 |
| Jul 13, 2026 | Baird | Maintained | Neutral | $236.00 |
| Apr 22, 2026 | Truist Securities | Maintained | Hold | $225.00 |
| Apr 22, 2026 | Barclays | Maintained | Overweight | $230.00 |
| Apr 22, 2026 | Baird | Maintained | Neutral | $229.00 |
| Apr 22, 2026 | UBS | Maintained | Neutral | $220.00 |
| Apr 8, 2026 | Evercore ISI Group | Maintained | In-Line | $210.00 |
| Feb 12, 2026 | Mizuho | Maintained | Outperform | $235.00 |
| Feb 11, 2026 | Jefferies | Maintained | Buy | $220.00 |
| Feb 11, 2026 | Evercore ISI Group | Maintained | In-Line | $220.00 |
| Feb 11, 2026 | Barclays | Maintained | Overweight | $225.00 |
| Feb 11, 2026 | UBS | Maintained | Neutral | $210.00 |

## Frequently Asked Questions

### What is the latest analyst rating on DGX?

On Oct 7, 2026, Barclays maintained Quest Diagnostics at Overweight with a price target of $260.00.

## Similar Stocks

- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [LH](https://www.lighthorse.io/tickers/lh) — Labcorp Holdings Inc. Common Stock
- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).